Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Adagene Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +8 vs. Q4 2025
- Shares held
- 3.30M
- +210.8K (+6.8%) vs. Q4 2025
- Total value
- $9.70M
- +$3.67M (+60.9%) vs. Q4 2025
- New holders
- 11
- 3 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $81.0M |
| Q1 2026 | 25 | $9.70M |
| Q4 2025 | 17 | $6.03M |
| Q3 2025 | 17 | $11.3M |
| Q2 2025 | 15 | $11.8M |
| Q1 2025 | 14 | $11.6M |
| Q4 2024 | 15 | $20.3M |
| Q3 2024 | 13 | $25.3M |
| Q2 2024 | 14 | $33.7M |
| Q1 2024 | 17 | $34.3M |
| Q4 2023 | 11 | $15.5M |
| Q3 2023 | 10 | $6.16M |
| Q2 2023 | 10 | $6.02M |
| Q1 2023 | 11 | $6.02M |
| Q4 2022 | 9 | $5.58M |
| Q3 2022 | 11 | $7.60M |
| Q2 2022 | 15 | $15.4M |
| Q1 2022 | 15 | $29.7M |
| Q4 2021 | 16 | $67.3M |
| Q3 2021 | 19 | $126.6M |
| Q2 2021 | 16 | $80.5M |
| Q1 2021 | 27 | $115.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Adagene Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 28 | $110 | 0.00% | +28 | New |
| SBI Securities Co., Ltd. | 69 | $270 | 0.00% | −33−32.4% | Reduced |
| Barclays PLC | 400 | $1.57K | 0.00% | +400 | New |
| BlackRock, Inc. | 635 | $2.49K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 712 | $2.70K | 0.00% | +712 | New |
| EverSource Wealth Advisors, LLC | 2,473 | $9.69K | 0.00% | −5−0.2% | Reduced |
| BNP Paribas Arbitrage, SA | 3,700 | $14.5K | 0.00% | +2,000+117.6% | Added |
| UBS Group AG | 4,002 | $15.7K | 0.00% | +1,449+56.8% | Added |
| Geode Capital Management, LLC | 10,309 | $40.4K | 0.00% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 11,617 | $45.5K | 0.00% | +11,617 | New |
| Nomura Holdings Inc | 14,710 | $57.7K | 0.00% | −3,290−18.3% | Reduced |
| Royal Bank of Canada | 16,850 | $66.0K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 20,710 | $81.2K | 0.00% | +20,710 | New |
| Jane Street Group, LLC | 30,425 | $119.3K | 0.00% | +30,425 | New |
| Renaissance Technologies LLC | 34,533 | $135.4K | 0.00% | +34,533 | New |
| Dauntless Investment Group, LLC | 34,775 | $136.3K | 0.38% | +34,775 | New |
| Persistent Asset Partners Ltd | 35,126 | $137.7K | 0.05% | +35,126 | New |
| Kamunting Street Capital Management, L.P. | 38,070 | $149.0K | 0.08% | −87,962−69.8% | Reduced |
| SmartHarvest Portfolios, LLC | 40,312 | $158.0K | 0.07% | +1,541+4.0% | Added |
| Invesco Ltd. | 47,124 | $184.7K | 0.00% | +47,124 | New |
| Morgan Stanley | 66,148 | $259.3K | 0.00% | −9,497−12.6% | Reduced |
| Mill Creek Capital Advisors, LLC | 199,610 | $782.5K | 0.02% | 00.0% | Unchanged |
| SC China Holding Ltd | 1,343,364 | $2.03M | 0.13% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 607,903 | $2.38M | 0.00% | +607,903 | New |
| Exome Asset Management LLC | 736,845 | $2.89M | 1.70% | −323,376−30.5% | Reduced |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −48,385−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −12−100.0% | Sold out |